301211 亨迪药业
已收盘 07-02 15:00:00
资讯
新帖
简况
亨迪药业(301211)6月18日股东户数1.81万户,较上期减少1.79%
证券之星 · 07-01 17:43
亨迪药业(301211)6月18日股东户数1.81万户,较上期减少1.79%
异动快报:亨迪药业(301211)6月23日9点38分触及涨停板
证券之星 · 06-23
异动快报:亨迪药业(301211)6月23日9点38分触及涨停板
亨迪药业:截至2026年6月10日,公司股东户数为18,382户
证券之星 · 06-17
亨迪药业:截至2026年6月10日,公司股东户数为18,382户
亨迪药业:未收到质押股份触及平仓线通知
证券之星 · 06-10
亨迪药业:未收到质押股份触及平仓线通知
亨迪药业(301211)5月29日股东户数1.87万户,较上期减少0.97%
证券之星 · 06-05
亨迪药业(301211)5月29日股东户数1.87万户,较上期减少0.97%
亨迪药业:截至2026年5月29日,公司股东户数为18,749户
证券之星 · 06-05
亨迪药业:截至2026年5月29日,公司股东户数为18,749户
股市必读:亨迪药业(301211)股东户数1.89万户,较上期减少4.92%
证券之星 · 06-01
股市必读:亨迪药业(301211)股东户数1.89万户,较上期减少4.92%
亨迪药业(301211)5月20日股东户数1.89万户,较上期减少4.92%
证券之星 · 05-29
亨迪药业(301211)5月20日股东户数1.89万户,较上期减少4.92%
亨迪药业(301211.SZ):右旋布洛芬原料药通过巴西国家卫生监督局GMP认证
智通财经 · 05-07
亨迪药业(301211.SZ):右旋布洛芬原料药通过巴西国家卫生监督局GMP认证
亨迪药业:截至2026年4月30日,公司股东户数为19,911户
证券之星 · 05-07
亨迪药业:截至2026年4月30日,公司股东户数为19,911户
每周股票复盘:亨迪药业(301211)股东户数减少2.08%,户均持股上升
证券之星 · 05-03
每周股票复盘:亨迪药业(301211)股东户数减少2.08%,户均持股上升
亨迪药业:截至2026年4月20日,公司股东户数为20,103户
证券之星 · 04-27
亨迪药业:截至2026年4月20日,公司股东户数为20,103户
亨迪药业(301211)2026年一季报简析:增收不增利
证券之星 · 04-24
亨迪药业(301211)2026年一季报简析:增收不增利
亨迪药业(301211.SZ)发布一季度业绩,归母净利润921.81万元,下降10.73%
智通财经 · 04-22
亨迪药业(301211.SZ)发布一季度业绩,归母净利润921.81万元,下降10.73%
股市必读:亨迪药业(301211)4月16日披露最新机构调研信息
证券之星 · 04-17
股市必读:亨迪药业(301211)4月16日披露最新机构调研信息
亨迪药业:截至2026年4月10日,公司股东户数为20,531户
证券之星 · 04-15
亨迪药业:截至2026年4月10日,公司股东户数为20,531户
亨迪药业(301211)3月31日股东户数2.07万户,较上期增加2.92%
证券之星 · 04-07
亨迪药业(301211)3月31日股东户数2.07万户,较上期增加2.92%
亨迪药业(301211.SZ)发布2025年度业绩,归母净利润3491.06万元,下降61.87%
智通财经网 · 03-30
亨迪药业(301211.SZ)发布2025年度业绩,归母净利润3491.06万元,下降61.87%
亨迪药业:截至2026年3月20日,公司股东户数为20,155户
证券之星 · 03-25
亨迪药业:截至2026年3月20日,公司股东户数为20,155户
亨迪药业:截至2026年3月10日,公司股东户数为20,200户
证券之星 · 03-16
亨迪药业:截至2026年3月10日,公司股东户数为20,200户
加载更多
公司概况
公司名称:
湖北亨迪药业股份有限公司
所属行业:
医药制造业
上市日期:
2021-12-22
主营业务:
湖北亨迪药业股份有限公司的主营业务是化学原料药(含中间体)及制剂产品的研发、生产和销售,根据客户需求提供合同研发生产服务(CDMO)。公司的主要产品是布洛芬、右旋布洛芬、托拉塞米、米力农、醋酸阿比特龙、磷酸氟达拉滨、盐酸格拉司琼、克拉屈滨、硫酸莨菪碱、硫酸阿托品、布洛芬颗粒、布洛芬片、布洛芬缓释胶囊、布洛芬混悬液、布洛伪麻片、奥沙普秦肠溶片、奥沙普秦肠溶胶囊、托拉塞米片、托拉塞米注射剂、巴柳氮钠颗粒、多维元素片。公司是湖北省高新技术企业,公司历年来注重新技术、新工艺和新产品研发,先后承担了多项省级科研项目,相关产品多次荣获湖北省科技进步奖等。
发行价格:
25.80
{"stockData":{"symbol":"301211","market":"SZ","secType":"STK","nameCN":"亨迪药业","latestPrice":12.34,"timestamp":1782975795000,"preClose":11.71,"halted":0,"volume":29955456,"delay":0,"changeRate":0.0538,"floatShares":418000000,"shares":418000000,"eps":0.081,"marketStatus":"已收盘","change":0.63,"latestTime":"07-02 15:00:00","open":11.6,"high":12.68,"low":11.51,"amount":364000000,"amplitude":0.0999,"askPrice":12.35,"askSize":1327,"bidPrice":12.34,"bidSize":1270,"shortable":0,"etf":0,"ttmEps":0.081,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1783042200000},"marketStatusCode":5,"adr":0,"adjPreClose":11.71,"symbolType":"stock","openAndCloseTimeList":[[1782955800000,1782963000000],[1782968400000,1782975600000]],"highLimit":12.88,"lowLimit":10.54,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":417600000,"isCdr":false,"pbRate":2.14,"roa":"--","peRate":152.345679,"roe":"0.4%","epsLYR":0.08,"committee":0.041167,"marketValue":5153000000,"turnoverRate":0.0717,"status":0,"floatMarketCap":5153000000},"requestUrl":"/m/hq/s/301211","defaultTab":"news","newsList":[{"id":"2648511305","title":"亨迪药业(301211)6月18日股东户数1.81万户,较上期减少1.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648511305","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648511305?lang=zh_cn&edition=full","pubTime":"2026-07-01 17:43","pubTimestamp":1782899003,"startTime":"0","endTime":"0","summary":"证券之星消息,近日亨迪药业披露,截至2026年6月18日公司股东户数为1.81万户,较6月10日减少329.0户,减幅为1.79%。在化学制药行业个股中,亨迪药业股东户数低于行业平均水平,截至6月18日,化学制药行业平均股东户数为3.53万户。从股价来看,2026年6月10日至2026年6月18日,亨迪药业区间跌幅为1.05%,在此期间股东户数减少329.0户,减幅为1.79%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070100034020.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301211","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645001636","title":"异动快报:亨迪药业(301211)6月23日9点38分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2645001636","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645001636?lang=zh_cn&edition=full","pubTime":"2026-06-23 09:46","pubTimestamp":1782179171,"startTime":"0","endTime":"0","summary":"证券之星6月23日盘中消息,9点38分亨迪药业(301211)触及涨停板。其所属行业化学制药目前上涨。领涨股为新华制药。该股为化学原料药,医药,流感概念热股,当日化学原料药概念上涨3.09%,医药概念上涨2.96%,流感概念上涨1.99%。6月22日的资金流向数据方面,主力资金净流出101.5万元,占总成交额3.14%,游资资金净流出74.44万元,占总成交额2.31%,散户资金净流入175.94万元,占总成交额5.45%。近5日资金流向一览见下表:亨迪药业主要指标及行业内排名如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062300009858.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301211","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644715223","title":"亨迪药业:截至2026年6月10日,公司股东户数为18,382户","url":"https://stock-news.laohu8.com/highlight/detail?id=2644715223","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644715223?lang=zh_cn&edition=full","pubTime":"2026-06-17 15:09","pubTimestamp":1781680153,"startTime":"0","endTime":"0","summary":"证券之星消息,亨迪药业(301211)06月17日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘您好!请问截止6月10号,公司的股东人数是多少?谢谢亨迪药业回复:感谢您对公司的关注,截至2026年6月10日,公司股东户数为18,382户。本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:沈彬","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061700020241.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301211","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642416628","title":"亨迪药业:未收到质押股份触及平仓线通知","url":"https://stock-news.laohu8.com/highlight/detail?id=2642416628","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642416628?lang=zh_cn&edition=full","pubTime":"2026-06-10 08:57","pubTimestamp":1781053029,"startTime":"0","endTime":"0","summary":"证券之星消息,亨迪药业06月09日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘您好,向公司求证四个问题:1、实控人及一致行动人大额股权质押,前期市场测算原平仓线约10.46元,近期股价长期运行在9.6元附近,已经跌破原平仓价格。截至目前,公司未收到实际控制人之一致行动人关于质押股份触及平仓线或需强制平仓的通知,不存在应披露而未披露的重大事项。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061000007771.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641190441","title":"亨迪药业(301211)5月29日股东户数1.87万户,较上期减少0.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2641190441","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641190441?lang=zh_cn&edition=full","pubTime":"2026-06-05 17:37","pubTimestamp":1780652240,"startTime":"0","endTime":"0","summary":"证券之星消息,近日亨迪药业披露,截至2026年5月29日公司股东户数为1.87万户,较5月20日减少183.0户,减幅为0.97%。在化学制药行业个股中,亨迪药业股东户数低于行业平均水平,截至5月29日,化学制药行业平均股东户数为3.54万户。从股价来看,2026年5月20日至2026年5月29日,亨迪药业区间跌幅为6.53%,在此期间股东户数减少183.0户,减幅为0.97%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060500030563.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641191714","title":"亨迪药业:截至2026年5月29日,公司股东户数为18,749户","url":"https://stock-news.laohu8.com/highlight/detail?id=2641191714","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641191714?lang=zh_cn&edition=full","pubTime":"2026-06-05 11:35","pubTimestamp":1780630535,"startTime":"0","endTime":"0","summary":"证券之星消息,亨迪药业(301211)06月05日在投资者关系平台上答复投资者关心的问题。投资者提问:您好,请问截止5月31日,公司股东户数是多少?亨迪药业回复:感谢您对公司的关注,截至2026年5月29日,公司股东户数为18,749户。本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060500015332.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301211","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640916986","title":"股市必读:亨迪药业(301211)股东户数1.89万户,较上期减少4.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640916986","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640916986?lang=zh_cn&edition=full","pubTime":"2026-06-01 05:26","pubTimestamp":1780262775,"startTime":"0","endTime":"0","summary":"截至2026年5月29日收盘,亨迪药业报收于10.16元,上涨0.49%,换手率0.74%,成交量3.08万手,成交额3128.81万元。交易信息汇总资金流向5月29日主力资金净流出9.18万元;游资资金净流入119.19万元;散户资金净流出110.01万元。股本股东变化股东户数变动近日亨迪药业披露,截至2026年5月20日公司股东户数为1.89万户,较4月30日减少979.0户,减幅为4.92%。户均持股数量由上期的2.1万股增加至2.21万股,户均持股市值为23.98万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060100002294.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639557626","title":"亨迪药业(301211)5月20日股东户数1.89万户,较上期减少4.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2639557626","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639557626?lang=zh_cn&edition=full","pubTime":"2026-05-29 17:52","pubTimestamp":1780048367,"startTime":"0","endTime":"0","summary":"证券之星消息,近日亨迪药业披露,截至2026年5月20日公司股东户数为1.89万户,较4月30日减少979.0户,减幅为4.92%。在化学制药行业个股中,亨迪药业股东户数低于行业平均水平,截至5月20日,化学制药行业平均股东户数为3.56万户。从股价来看,2026年4月30日至2026年5月20日,亨迪药业区间跌幅为5.4%,在此期间股东户数减少979.0户,减幅为4.92%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052900033430.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633113002","title":"亨迪药业(301211.SZ):右旋布洛芬原料药通过巴西国家卫生监督局GMP认证","url":"https://stock-news.laohu8.com/highlight/detail?id=2633113002","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633113002?lang=zh_cn&edition=full","pubTime":"2026-05-07 16:04","pubTimestamp":1778141084,"startTime":"0","endTime":"0","summary":"智通财经APP讯,亨迪药业(301211.SZ)发布公告,公司于2025年11月24日至2025年11月28日接受了巴西国家卫生监督局(简称“巴西ANVISA”)官方的现场GMP(药品生产质量管理规范)认证,认证范围为化学原料药:右旋布洛芬。近日,公司收到巴西ANVISA核准签发的药品生产质量管理规范(GMP)认证证书。巴西是南美洲最大的国家,本次公司右旋布洛芬原料药顺利通过巴西国家卫生监督局的GMP认证,为公司产品成功进入巴西市场创造了条件,对其进一步拓展巴西市场和其他国际市场奠定坚实基础,有利于提升公司的国际竞争力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1439023.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301211","BK0239","159100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633190956","title":"亨迪药业:截至2026年4月30日,公司股东户数为19,911户","url":"https://stock-news.laohu8.com/highlight/detail?id=2633190956","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633190956?lang=zh_cn&edition=full","pubTime":"2026-05-07 15:04","pubTimestamp":1778137461,"startTime":"0","endTime":"0","summary":"证券之星消息,亨迪药业(301211)05月07日在投资者关系平台上答复投资者关心的问题。投资者提问:请问截止2026年4月 30日公司的股东总数是多少?谢谢亨迪药业回复:感谢您对公司的关注,截至2026年4月30日,公司股东户数为19,911户。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050700018578.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632608787","title":"每周股票复盘:亨迪药业(301211)股东户数减少2.08%,户均持股上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2632608787","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632608787?lang=zh_cn&edition=full","pubTime":"2026-05-03 08:44","pubTimestamp":1777769049,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘,亨迪药业报收于11.49元,较上周的11.4元上涨0.79%。本周,亨迪药业4月28日盘中最高价报11.64元。本周关注点股本股东变化:截至2026年4月20日股东户数为2.01万户,较前期减少2.08%股本股东变化:户均持股数量由2.03万股增至2.08万股,户均持股市值达24.76万元股本股东变化股东户数变动截至2026年4月20日,公司股东户数为2.01万户,较4月10日减少428.0户,减幅为2.08%。户均持股数量由上期的2.03万股增加至2.08万股,户均持股市值为24.76万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050300002179.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630567373","title":"亨迪药业:截至2026年4月20日,公司股东户数为20,103户","url":"https://stock-news.laohu8.com/highlight/detail?id=2630567373","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630567373?lang=zh_cn&edition=full","pubTime":"2026-04-27 11:36","pubTimestamp":1777260983,"startTime":"0","endTime":"0","summary":"证券之星消息,亨迪药业(301211)04月27日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘您好!请问截止4月20号,公司的股东人数是多少?谢谢亨迪药业回复:感谢您对公司的关注,截至2026年4月20日,公司股东户数为20,103户。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042700017722.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629828695","title":"亨迪药业(301211)2026年一季报简析:增收不增利","url":"https://stock-news.laohu8.com/highlight/detail?id=2629828695","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629828695?lang=zh_cn&edition=full","pubTime":"2026-04-24 22:47","pubTimestamp":1777042043,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期亨迪药业发布2026年一季报。根据财报显示,亨迪药业增收不增利。截至本报告期末,公司营业总收入1.2亿元,同比上升5.0%,归母净利润921.81万元,同比下降10.73%。受益于使用人群庞大,随着老龄化加剧,布洛芬制剂需求将持续释放。公司目前已有片剂、颗粒剂、缓释胶囊和混悬剂等布洛芬剂型获批上市,注射剂研发进展顺利。未来将继续加大资源投入,将公司的布洛芬制剂板块做大做强。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042400066030.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301211","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629011667","title":"亨迪药业(301211.SZ)发布一季度业绩,归母净利润921.81万元,下降10.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629011667","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629011667?lang=zh_cn&edition=full","pubTime":"2026-04-22 17:34","pubTimestamp":1776850474,"startTime":"0","endTime":"0","summary":"智通财经APP讯,亨迪药业(301211.SZ)发布2026年第一季度报告,该公司营业收入为1.2亿元,同比增长5.00%。归属于上市公司股东的净利润为921.81万元,同比减少10.73%。归属于上市公司股东的扣除非经常性损益的净利润为251.88万元,同比增长0.24%。基本每股收益为0.02元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1431978.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628245331","title":"股市必读:亨迪药业(301211)4月16日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2628245331","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628245331?lang=zh_cn&edition=full","pubTime":"2026-04-17 03:00","pubTimestamp":1776366037,"startTime":"0","endTime":"0","summary":"截至2026年4月16日收盘,亨迪药业报收于12.23元,下跌0.08%,换手率0.82%,成交量3.42万手,成交额4153.09万元。来自机构调研要点:公司布洛芬制剂市场需求持续释放,多剂型已上市,注射剂研发进展顺利。截至目前,公司、控股股东及实际控制人、持股5%以上股东均无应披露而未披露的重大事项或处于筹划阶段的重大事项。2025年实现营业收入453,306,981.13元,同比增长1.67%;归母净利润34,910,598.79元,同比下降61.87%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041700003411.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627404793","title":"亨迪药业:截至2026年4月10日,公司股东户数为20,531户","url":"https://stock-news.laohu8.com/highlight/detail?id=2627404793","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627404793?lang=zh_cn&edition=full","pubTime":"2026-04-15 16:15","pubTimestamp":1776240912,"startTime":"0","endTime":"0","summary":"证券之星消息,亨迪药业(301211)04月15日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘您好!请问截止4月10号,公司的股东人数是多少?谢谢亨迪药业回复:感谢您对公司的关注,截至2026年4月10日,公司股东户数为20,531户。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041500028732.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625936626","title":"亨迪药业(301211)3月31日股东户数2.07万户,较上期增加2.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2625936626","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625936626?lang=zh_cn&edition=full","pubTime":"2026-04-07 17:13","pubTimestamp":1775553189,"startTime":"0","endTime":"0","summary":"证券之星消息,近日亨迪药业披露,截至2026年3月31日公司股东户数为2.07万户,较3月20日增加588.0户,增幅为2.92%。在化学制药行业个股中,亨迪药业股东户数低于行业平均水平,截至3月31日,化学制药行业平均股东户数为3.47万户。从股价来看,2026年3月20日至2026年3月31日,亨迪药业区间涨幅为2.47%,在此期间股东户数增加588.0户,增幅为2.92%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040700024053.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301211","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623339759","title":"亨迪药业(301211.SZ)发布2025年度业绩,归母净利润3491.06万元,下降61.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2623339759","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623339759?lang=zh_cn&edition=full","pubTime":"2026-03-30 16:14","pubTimestamp":1774858465,"startTime":"0","endTime":"0","summary":"亨迪药业(301211.SZ)发布2025年年度报告,该公司营业收入为4.53亿元,同比增长1.67%。归属于上市公司股东的净利润为3491.06万元,同比减少61.87%。归属于上市公司股东的扣除非经常性损益的净利润为788.35万元,同比减少89.19%。基本每股收益为0.08元。此外,拟向全体股东每10股派发现金红利0.6元(含税)。","market":"us","thumbnail":"https://img.zhitongcaijing.com/astock/8.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/astock/8.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1421701.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["301211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622040350","title":"亨迪药业:截至2026年3月20日,公司股东户数为20,155户","url":"https://stock-news.laohu8.com/highlight/detail?id=2622040350","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622040350?lang=zh_cn&edition=full","pubTime":"2026-03-25 15:00","pubTimestamp":1774422054,"startTime":"0","endTime":"0","summary":"证券之星消息,亨迪药业(301211)03月24日在投资者关系平台上答复投资者关心的问题。投资者提问:尊敬的董秘,您好!敬请发布截至3月20日公司的股东户数信息,谢谢!亨迪药业回复:感谢您对公司的关注,截至2026年3月20日,公司股东户数为20,155户。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032500023412.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619322324","title":"亨迪药业:截至2026年3月10日,公司股东户数为20,200户","url":"https://stock-news.laohu8.com/highlight/detail?id=2619322324","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619322324?lang=zh_cn&edition=full","pubTime":"2026-03-16 15:07","pubTimestamp":1773644837,"startTime":"0","endTime":"0","summary":"证券之星消息,亨迪药业(301211)03月16日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘您好!请问截止3月10号,公司的股东人数是多少?谢谢亨迪药业回复:感谢您对公司的关注,截至2026年3月10日,公司股东户数为20,200户。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031600014272.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301211"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1782998798298,"stockEarnings":[{"period":"1week","weight":0.0218},{"period":"1month","weight":0.1509},{"period":"3month","weight":-0.0542},{"period":"6month","weight":-0.0356},{"period":"1year","weight":-0.0647},{"period":"ytd","weight":-0.0356}],"compareEarnings":[{"period":"1week","weight":0.0004},{"period":"1month","weight":0.0135},{"period":"3month","weight":0.0493},{"period":"6month","weight":0.0362},{"period":"1year","weight":0.1893},{"period":"ytd","weight":0.0362}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"湖北亨迪药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"18053人(较上一季度减少1.79%)","perCapita":"23131股","listingDate":"2021-12-22","address":"湖北省荆门市掇刀区杨湾路122号","registeredCapital":"41760万元","survey":" 湖北亨迪药业股份有限公司的主营业务是化学原料药(含中间体)及制剂产品的研发、生产和销售,根据客户需求提供合同研发生产服务(CDMO)。公司的主要产品是布洛芬、右旋布洛芬、托拉塞米、米力农、醋酸阿比特龙、磷酸氟达拉滨、盐酸格拉司琼、克拉屈滨、硫酸莨菪碱、硫酸阿托品、布洛芬颗粒、布洛芬片、布洛芬缓释胶囊、布洛芬混悬液、布洛伪麻片、奥沙普秦肠溶片、奥沙普秦肠溶胶囊、托拉塞米片、托拉塞米注射剂、巴柳氮钠颗粒、多维元素片。公司是湖北省高新技术企业,公司历年来注重新技术、新工艺和新产品研发,先后承担了多项省级科研项目,相关产品多次荣获湖北省科技进步奖等。","listedPrice":25.8},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"亨迪药业(301211)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供亨迪药业(301211)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"亨迪药业,301211,亨迪药业股票,亨迪药业股票老虎,亨迪药业股票老虎国际,亨迪药业行情,亨迪药业股票行情,亨迪药业股价,亨迪药业股市,亨迪药业股票价格,亨迪药业股票交易,亨迪药业股票购买,亨迪药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"亨迪药业(301211)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供亨迪药业(301211)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}